{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:49:28Z","timestamp":1790707768644,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,14]],"date-time":"2012-04-14T00:00:00Z","timestamp":1334361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12031-012-9762-0","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T01:49:14Z","timestamp":1334281754000},"page":"482-492","source":"Crossref","is-referenced-by-count":110,"title":["PACAP is an Endogenous Protective Factor\u2014Insights from PACAP-Deficient Mice"],"prefix":"10.1007","volume":"48","author":[{"given":"D.","family":"Reglodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Szabadfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Atlasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Szakaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lubics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Laszlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Brubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vincze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Helyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Welke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,14]]},"reference":[{"key":"9762_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/138161211795589364","volume":"17","author":"C Abad","year":"2011","unstructured":"Abad C, Waschek JA (2011) Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis. Curr Pharm Des 17:1025\u20131035","journal-title":"Curr Pharm Des"},{"key":"9762_CR2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.neuroscience.2010.10.044","volume":"172","author":"Y Ago","year":"2011","unstructured":"Ago Y, Yoneyama M, Ishihama T et al (2011) Role of endogenous pituitary adenylate cyclase-activating polypeptide in adult hippocampal neurogenesis. Neuroscience 172:554\u2013561","journal-title":"Neuroscience"},{"key":"9762_CR3","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/j.1460-9568.2007.05535.x","volume":"25","author":"A Allais","year":"2007","unstructured":"Allais A, Burel D, Isaac ER et al (2007) Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide. Eur J Neurosci 25:2604\u20132618","journal-title":"Eur J Neurosci"},{"key":"9762_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.npep.2010.10.002","volume":"45","author":"EN Alston","year":"2011","unstructured":"Alston EN, Parrish DC, Hasan W, Tharp K, Pahlmeyer L, Habecker BA (2011) Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms. Neuropeptides 45:33\u201342","journal-title":"Neuropeptides"},{"key":"9762_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2007.09.084","volume":"151","author":"BD Armstrong","year":"2008","unstructured":"Armstrong BD, Abad C, Chhith S et al (2008) Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience 151:63\u201373","journal-title":"Neuroscience"},{"key":"9762_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.2010.05512.x","volume":"1200","author":"T Atlasz","year":"2010","unstructured":"Atlasz T, Szabadfi K, Kiss P et al (2010) Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Ann NY Acad Sci 1200:128\u2013139","journal-title":"Ann NY Acad Sci"},{"key":"9762_CR7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygcen.2006.12.022","volume":"153","author":"T Atlasz","year":"2007","unstructured":"Atlasz T, Babai N, Kiss P et al (2007) Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats. Gen Comp Endocrinol 153:108\u2013114","journal-title":"Gen Comp Endocrinol"},{"key":"9762_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcp.21381","volume":"216","author":"YT Azuma","year":"2008","unstructured":"Azuma YT, Hagi K, Shintani N et al (2008) PACAP provides colonic protection against dextran sodium sulfate induced colitis. J Cell Physiol 216:111\u2013119","journal-title":"J Cell Physiol"},{"key":"9762_CR9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12640-010-9186-y","volume":"19","author":"B Botia","year":"2011","unstructured":"Botia B, Jolivel V, Burel D et al (2011) Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum. Neurotox Res 19:423\u2013434","journal-title":"Neurotox Res"},{"key":"9762_CR10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2006.06.016","volume":"137","author":"Y Chen","year":"2006","unstructured":"Chen Y, Samal B, Hamelink CR et al (2006) Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept 137:4\u201319","journal-title":"Regul Pept"},{"key":"9762_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12031-008-9087-1","volume":"36","author":"A Dejda","year":"2008","unstructured":"Dejda A, Jolivel V, Bourgault S et al (2008) Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J Mol Neurosci 36:26\u201337","journal-title":"J Mol Neurosci"},{"key":"9762_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-0115(02)00190-8","volume":"109","author":"K Dohi","year":"2002","unstructured":"Dohi K, Mizushima H, Nakajo S et al (2002) Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK\/SAPK and p38 signal transduction pathways. Regul Pept 109:83\u201388","journal-title":"Regul Pept"},{"key":"9762_CR13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.peptides.2011.05.008","volume":"32","author":"K Elekes","year":"2011","unstructured":"Elekes K, Sandor K, Moricz A et al (2011) Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: in vivo study with gene-deleted mice. Peptides 32:1439\u20131446","journal-title":"Peptides"},{"key":"9762_CR14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12031-010-9434-x","volume":"43","author":"K Endo","year":"2011","unstructured":"Endo K, Nakamachi T, Seki T et al (2011) Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse. J Mol Neurosci 43:22\u201329","journal-title":"J Mol Neurosci"},{"key":"9762_CR15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12031-008-9132-0","volume":"37","author":"A Ferencz","year":"2009","unstructured":"Ferencz A, Racz B, Tamas A et al (2009) Influence of PACAP on oxidative stress and tissue injury following small-bowel autotransplantation. J Mol Neurosci 37:168\u2013176","journal-title":"J Mol Neurosci"},{"key":"9762_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12031-010-9357-6","volume":"42","author":"A Ferencz","year":"2010","unstructured":"Ferencz A, Kiss P, Gy W et al (2010a) Comparison of intestinal warm ischemic injury in PACAP knockout and wild-type mice. J Mol Neurosci 42:435\u2013442","journal-title":"J Mol Neurosci"},{"key":"9762_CR17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12031-010-9352-y","volume":"42","author":"A Ferencz","year":"2010","unstructured":"Ferencz A, Gy W, Zs H, Hashimoto H, Baba A, Reglodi D (2010b) Presence of endogenous PACAP-38 ameliorated intestinal cold preservation tissue injury. J Mol Neurosci 42:428\u2013434","journal-title":"J Mol Neurosci"},{"key":"9762_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.peptides.2005.06.022","volume":"27","author":"B Gasz","year":"2006","unstructured":"Gasz B, Racz B, Roth E et al (2006) Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 27:87\u201394","journal-title":"Peptides"},{"key":"9762_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2011.11.046","volume":"202","author":"B Gaszner","year":"2012","unstructured":"Gaszner B, Kormos V, Kozicz T, Hashimoto H, Reglodi D, Helyes Zs (2012) The behavioral phenotype of pituitary adenylate cyclase-activating polypeptide deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus. Neuroscience 202:283\u2013299","journal-title":"Neuroscience"},{"key":"9762_CR20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1210\/me.15.10.1739","volume":"15","author":"SL Gray","year":"2001","unstructured":"Gray SL, Cummings KJ, Jirik FR, Sherwood NM (2001) Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15:1739\u20131747","journal-title":"Mol Endocrinol"},{"key":"9762_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1073\/pnas.012608999","volume":"99","author":"C Hamelink","year":"2002","unstructured":"Hamelink C, Tjurmina O, Damadzic R et al (2002) Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci USA 99:461\u2013466","journal-title":"Proc Natl Acad Sci USA"},{"key":"9762_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(06)51001-0","volume":"251","author":"J Hannibal","year":"2006","unstructured":"Hannibal J (2006) Roles of PACAP-containing retinal ganglion cells in circadian timing. Int Rev Cytol 251:1\u201339","journal-title":"Int Rev Cytol"},{"key":"9762_CR23","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1073\/pnas.231094498","volume":"98","author":"H Hashimoto","year":"2001","unstructured":"Hashimoto H, Shintani N, Tanaka K et al (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355\u201313360","journal-title":"Proc Natl Acad Sci USA"},{"key":"9762_CR24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2174\/138161211795589382","volume":"17","author":"H Hashimoto","year":"2011","unstructured":"Hashimoto H, Shintani N, Tanida M, Hayata A, Hashimoto R, Baba A (2011) PACAP is implicated in the stress axes. Curr Pharm Des 17:985\u2013989","journal-title":"Curr Pharm Des"},{"key":"9762_CR25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2009.06168.x","volume":"110","author":"H Hashimoto","year":"2009","unstructured":"Hashimoto H, Hashimoto R, Shintani N et al (2009) Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. J Neurochem 110:595\u2013602","journal-title":"J Neurochem"},{"key":"9762_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2008.08.030","volume":"444","author":"M Hatanaka","year":"2008","unstructured":"Hatanaka M, Tanida M, Shintani N et al (2008) Lack of light-induced elevation of renal sympathetic nerve activity and plasma corticosterone levels in PACAP-deficient mice. Neurosci Lett 444:153\u2013156","journal-title":"Neurosci Lett"},{"key":"9762_CR27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2009.11.046","volume":"469","author":"G Horvath","year":"2010","unstructured":"Horvath G, Mark L, Brubel R et al (2010a) Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro. Neurosci Lett 469:70\u201374","journal-title":"Neurosci Lett"},{"key":"9762_CR28","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.transproceed.2010.05.015","volume":"42","author":"G Horvath","year":"2010","unstructured":"Horvath G, Racz B, Szakaly P et al (2010b) Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxia. Transplant Proc 42:2293\u20132295","journal-title":"Transplant Proc"},{"key":"9762_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mce.2007.09.003","volume":"280","author":"ER Isaac","year":"2008","unstructured":"Isaac ER, Sherwood NM (2008) Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice. Mol Cell Endocrinol 280:13\u201319","journal-title":"Mol Cell Endocrinol"},{"key":"9762_CR30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/1352458504ms1096oa","volume":"10","author":"H Kato","year":"2004","unstructured":"Kato H, Ito A, Kawanokuchi J et al (2004) Pituitary adenylate cyclase activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Mult Scler 10:651\u2013659","journal-title":"Mult Scler"},{"key":"9762_CR31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2003.09.004","volume":"310","author":"C Kawaguchi","year":"2003","unstructured":"Kawaguchi C, Tanaka K, Isojima Y et al (2003) Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem Biophys Res Commun 310:169\u2013175","journal-title":"Biochem Biophys Res Commun"},{"key":"9762_CR32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12031-010-9368-3","volume":"42","author":"A Kemeny","year":"2010","unstructured":"Kemeny A, Reglodi D, Cseharovszky R et al (2010) Pituitary adenylate cyclase-activating polypeptide deficiency enhances oxazolone-induced allergic contact dermatitis in mice. J Mol Neurosci 42:443\u2013449","journal-title":"J Mol Neurosci"},{"key":"9762_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-328X(96)00279-3","volume":"46","author":"JO Larsen","year":"1997","unstructured":"Larsen JO, Hannibal J, Knudsen SM, Fahrenkrug J (1997) Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) in the mesencephalic trigeminal nucleus of the rat after transection of the masseteric nerve. Mol Brain Res 46:109\u2013117","journal-title":"Mol Brain Res"},{"key":"9762_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.regpep.2007.09.012","volume":"145","author":"M Li","year":"2008","unstructured":"Li M, Maderdrut JL, Lertora JJ, Arimura A, Batuman V (2008) Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases. Regul Pept 145:24\u201332","journal-title":"Regul Pept"},{"key":"9762_CR35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12031-010-9394-1","volume":"43","author":"M Li","year":"2011","unstructured":"Li M, Balamuthusamy S, Khan AM, Maderdrut JL, Simon EE, Batuman V (2011) Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure. J Mol Neurosci 43:58\u201366","journal-title":"J Mol Neurosci"},{"key":"9762_CR36","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1523\/JNEUROSCI.0983-04.2004","volume":"24","author":"T Mabuchi","year":"2004","unstructured":"Mabuchi T, Shintani N, Matsumura S et al (2004) Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain. J Neurosci 24:7283\u20137291","journal-title":"J Neurosci"},{"key":"9762_CR37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nbd.2011.10.010","volume":"45","author":"A Markovics","year":"2012","unstructured":"Markovics A, Kormos V, Gaszner B et al (2012) Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis 45:633\u2013644","journal-title":"Neurobiol Dis"},{"key":"9762_CR38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-009-1476-9","volume":"204","author":"P Marquez","year":"2009","unstructured":"Marquez P, Bebawy D, Lelievre V et al (2009) The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice. Psychopharmacology 204:457\u2013463","journal-title":"Psychopharmacology"},{"key":"9762_CR39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12640-009-9049-6","volume":"16","author":"L Mester","year":"2009","unstructured":"Mester L, Szabo A, Atlasz T et al (2009) Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. Neurotox Res 16:68\u201376","journal-title":"Neurotox Res"},{"key":"9762_CR40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","volume":"164","author":"A Miyata","year":"1989","unstructured":"Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567\u2013574","journal-title":"Biochem Biophys Res Commun"},{"key":"9762_CR41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-8993(97)00923-2","volume":"775","author":"K Moller","year":"1997","unstructured":"Moller K, Reimer M, Ekblad E et al (1997) The effects of axotomy and preganglionic denervation on the expression of pituitary adenylate cyclase activating polypeptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion. Brain Res 775:166\u2013182","journal-title":"Brain Res"},{"key":"9762_CR42","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1253\/circj.CJ-09-1024","volume":"74","author":"H Mori","year":"2010","unstructured":"Mori H, Nakamachi T, Ohtaki H et al (2010) Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice. Circ J 74:1183\u20131190","journal-title":"Circ J"},{"key":"9762_CR43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/138161211795589346","volume":"17","author":"T Nakamachi","year":"2011","unstructured":"Nakamachi T, Farkas J, Watanabe J et al (2011) Role of PACAP in neural stem\/progenitor cell and astrocyte\u2014from neural development to neural repair. Curr Pharm Des 17:973\u2013984","journal-title":"Curr Pharm Des"},{"key":"9762_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-211-98811-4_6","volume":"106","author":"T Nakamachi","year":"2010","unstructured":"Nakamachi T, Ohtaki H, Yofu S et al (2010) Endogenous pituitary adenylate cyclase activating polypeptide is involved in suppression of edema in the ischemic brain. Acta Neurochir Suppl 106:43\u201346","journal-title":"Acta Neurochir Suppl"},{"key":"9762_CR45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12031-010-9383-4","volume":"42","author":"M Nakata","year":"2010","unstructured":"Nakata M, Shintani N, Hashimoto H, Baba A (2010) Intra-islet PACAP protects pancreatic beta-cells against glucotoxicity and lipotoicity. J Mol Neurosci 42:404\u2013410","journal-title":"J Mol Neurosci"},{"key":"9762_CR46","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/ijc.23308","volume":"122","author":"N Nemetz","year":"2008","unstructured":"Nemetz N, Abad C, Lawson G et al (2008) Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. Int J Cancer 122:1803\u20131809","journal-title":"Int J Cancer"},{"key":"9762_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.regpep.2004.08.034","volume":"126","author":"T Ogawa","year":"2005","unstructured":"Ogawa T, Nakamachi T, Ohtaki H et al (2005) Monoaminergic neuronal development is not affected in PACAP-gene-deficient mice. Regul Pept 126:103\u2013108","journal-title":"Regul Pept"},{"key":"9762_CR48","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.0600375103","volume":"103","author":"H Ohtaki","year":"2006","unstructured":"Ohtaki H, Nakamachi T, Dohi K et al (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci USA 103:7488\u20137493","journal-title":"Proc Natl Acad Sci USA"},{"key":"9762_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12031-008-9077-3","volume":"36","author":"H Ohtaki","year":"2008","unstructured":"Ohtaki H, Nakamachi T, Dohi K, Shioda S (2008) Role of PACAP in ischemic neural death. J Mol Neurosci 36:16\u201325","journal-title":"J Mol Neurosci"},{"key":"9762_CR50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12031-010-9350-0","volume":"42","author":"H Ohtaki","year":"2010","unstructured":"Ohtaki H, Satoh A, Nakamachi T et al (2010) Regulation of oxidative stress by pituitary adenylate cyclase-activating polypeptide (PACAP) mediated by PACAP receptor. J Mol Neurosci 42:397\u2013403","journal-title":"J Mol Neurosci"},{"key":"9762_CR51","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1111\/j.1742-4658.2008.06672.x","volume":"275","author":"S Onoue","year":"2008","unstructured":"Onoue S, Hanato J, Yamada S (2008) Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression. FEBS J 275:5542\u20135551","journal-title":"FEBS J"},{"key":"9762_CR52","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2174\/138161211795589328","volume":"17","author":"A Pinhasov","year":"2011","unstructured":"Pinhasov A, Nesher E, Gross M, Turgeman G, Kreinin A, Yadid G (2011) The role of the PACAP signaling system in depression. Curr Pharm Des 17:990\u20131001","journal-title":"Curr Pharm Des"},{"key":"9762_CR53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2007.09.015","volume":"145","author":"B Racz","year":"2008","unstructured":"Racz B, Gasz B, Gallyas F et al (2008) PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia\/reperfusion-induced cardiomyocyte apoptosis. Regul Pept 145:105\u2013115","journal-title":"Regul Pept"},{"key":"9762_CR54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12031-010-9349-6","volume":"42","author":"B Racz","year":"2010","unstructured":"Racz B, Reglodi D, Horvath G et al (2010) Protective effect of PACAP against doxorubicin-induced cell death in cardiomyocyte culture. J Mol Neurosci 42:419\u2013427","journal-title":"J Mol Neurosci"},{"key":"9762_CR55","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0196-9781(02)00262-0","volume":"23","author":"D Reglodi","year":"2002","unstructured":"Reglodi D, Tamas A, Somogyvari-Vigh A et al (2002) Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 23:2227\u20132234","journal-title":"Peptides"},{"key":"9762_CR56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2174\/138161211795589355","volume":"17","author":"D Reglodi","year":"2011","unstructured":"Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962\u2013972","journal-title":"Curr Pharm Des"},{"key":"9762_CR57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.npep.2011.05.001","volume":"46","author":"D Reglodi","year":"2012","unstructured":"Reglodi D, Kiss P, Horvath G et al (2012) Effects of pituitary adenylate cyclase activating polypeptide in the urinary system, with special emphasis on its protective effects in the kidney. Neuropeptides 46:61\u201370","journal-title":"Neuropeptides"},{"key":"9762_CR58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuropharm.2009.07.032","volume":"58","author":"M Riek-Burchardt","year":"2010","unstructured":"Riek-Burchardt M, Kolodziej A, Henrich-Noack P, Reymann KG, Hollt V, Stumm R (2010) Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia. Neuropharmacology 58:199\u2013207","journal-title":"Neuropharmacology"},{"key":"9762_CR59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12031-010-9424-z","volume":"43","author":"Y Sakurai","year":"2011","unstructured":"Sakurai Y, Shintani N, Hayata A, Hashimoto H, Baba A (2011a) Trophic effects of PACAP on pancreatic islets: a mini-review. J Mol Neurosci 43:3\u20137","journal-title":"J Mol Neurosci"},{"key":"9762_CR60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12031-010-9396-z","volume":"43","author":"Y Sakurai","year":"2011","unstructured":"Sakurai Y, Shintani N, Arimori A et al (2011b) Cerulein-induced acute pancreatitis in PACAP knockout mice. J Mol Neurosci 43:8\u201315","journal-title":"J Mol Neurosci"},{"key":"9762_CR61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.npep.2010.06.004","volume":"44","author":"K Sandor","year":"2010","unstructured":"Sandor K, Kormos V, Botz B et al (2010) Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice. Neuropeptides 44:363\u2013371","journal-title":"Neuropeptides"},{"key":"9762_CR62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-0115(02)00193-3","volume":"109","author":"H Sano","year":"2002","unstructured":"Sano H, Miyata A, Horio T, Nishikimi T, Matsuo H, Kangawa K (2002) The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor. Regul Pept 109:107\u2013113","journal-title":"Regul Pept"},{"key":"9762_CR63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138161211795049679","volume":"17","author":"T Seaborn","year":"2011","unstructured":"Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17:204\u2013214","journal-title":"Curr Pharm Des"},{"key":"9762_CR64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(01)02027-4","volume":"309","author":"CM Shin","year":"2001","unstructured":"Shin CM, Chung YH, Kim MJ, Cha CI (2001) Spatial and temporal distribution of pituitary adenylate cyclase activating polypeptide in gerbil global cerebral ischemia. Neurosci Lett 309:53\u201356","journal-title":"Neurosci Lett"},{"key":"9762_CR65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(02)00169-6","volume":"109","author":"N Shintani","year":"2002","unstructured":"Shintani N, Mori W, Hashimoto H et al (2002) Defects in reproductive functions in PACAP-deficient female mice. Regul Pept 109:45\u201348","journal-title":"Regul Pept"},{"key":"9762_CR66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0306-4522(98)00414-X","volume":"90","author":"Y Skoglosa","year":"1999","unstructured":"Skoglosa Y, Lewen A, Takei N, Hillered L, Lindholm D (1999) Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type I after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death. Neuroscience 90:235\u2013247","journal-title":"Neuroscience"},{"key":"9762_CR67","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2174\/1381612043383548","volume":"10","author":"A Somogyvari-Vigh","year":"2004","unstructured":"Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10:2861\u20132689","journal-title":"Curr Pharm Des"},{"key":"9762_CR68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2011.05904.x","volume":"1220","author":"N Stroth","year":"2011","unstructured":"Stroth N, Holighaus Y, Ait-Ali D, Eiden LE (2011) PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann NY Acad Sci 1220:49\u201359","journal-title":"Ann NY Acad Sci"},{"key":"9762_CR69","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1471-4159.2007.04895.x","volume":"103","author":"R Stumm","year":"2007","unstructured":"Stumm R, Kolodziej A, Prinz V, Endres M, Wu DF, Hollt V (2007) Pituitary adenylate cyclase activating polypeptide is up-regulated in cortical pyramidal cells after focal cerebral ischemia and protects neurons from mild hypoxic\/ischemic damage. J Neurochem 103:1666\u20131681","journal-title":"J Neurochem"},{"key":"9762_CR70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12640-011-9254-y","volume":"21","author":"K Szabadfi","year":"2012","unstructured":"Szabadfi K, Atlasz T, Kiss P et al (2012) Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo. Neurotox Res 21:41\u201348","journal-title":"Neurotox Res"},{"key":"9762_CR71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12031-008-9064-8","volume":"36","author":"P Szakaly","year":"2008","unstructured":"Szakaly P, Kiss P, Lubics A et al (2008) Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia\/reperfusion. J Mol Neurosci 36:89\u201396","journal-title":"J Mol Neurosci"},{"key":"9762_CR72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.npep.2010.12.003","volume":"45","author":"P Szakaly","year":"2011","unstructured":"Szakaly P, Laszlo E, Kovacs K et al (2011) Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia\/reperfusion injury. Neuropeptides 45:113\u2013121","journal-title":"Neuropeptides"},{"key":"9762_CR73","first-page":"249","volume":"23","author":"A Tamas","year":"2002","unstructured":"Tamas A, Reglodi D, Szanto Z, Borsiczky B, Nemeth J, Lengvari I (2002) Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats. Neuroendocrinol Lett 23:249\u2013254","journal-title":"Neuroendocrinol Lett"},{"key":"9762_CR74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12640-011-9298-z","volume":"21","author":"A Tamas","year":"2012","unstructured":"Tamas A, Szabadfi K, Nemeth A et al (2012) Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice. Neurotox Res 21:435\u2013444","journal-title":"Neurotox Res"},{"key":"9762_CR75","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.0812257106","volume":"106","author":"YV Tan","year":"2009","unstructured":"Tan YV, Abad C, Lopez R et al (2009) Pituitary adenylyl cyclase activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 106:2012\u20132017","journal-title":"Proc Natl Acad Sci USA"},{"key":"9762_CR76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.regpep.2004.05.017","volume":"123","author":"K Tanaka","year":"2004","unstructured":"Tanaka K, Hashimoto H, Shintani N, Yamamoto A, Baba A (2004) Reduced hypothermic and hypnotic responses to ethanol in PACAP-deficient mice. Regul Pept 123:95\u201398","journal-title":"Regul Pept"},{"key":"9762_CR77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1254\/jphs.FP0072173","volume":"107","author":"S Tomimoto","year":"2008","unstructured":"Tomimoto S, Ojika T, Shintani N et al (2008) Markedly reduced white adipose tissue and increased insulin sensitivity in Adcyap1-deficient mice. J Pharmacol Sci 107:41\u201348","journal-title":"J Pharmacol Sci"},{"key":"9762_CR78","unstructured":"Tsuchikawa D, Nakamachi T, Tsuchida M, Wada Y et al (2011) The neuroprotective effect of endogenous PACAP on spinal cord injury. Abstract. Presented at the 10th international Symposiumson VIP, PACAP and related peptides, 2011 Eilat, Israel"},{"key":"9762_CR79","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.peptides.2005.05.015","volume":"26","author":"D Vaudry","year":"2005","unstructured":"Vaudry D, Hamelink C, Damadzic R, Eskay RL, Gonzalez B, Eiden LE (2005) Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult. Peptides 26:2518\u20132524","journal-title":"Peptides"},{"key":"9762_CR80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault A et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharm Rev 61:283\u2013357","journal-title":"Pharm Rev"},{"key":"9762_CR81","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ijdevneu.2011.06.008","volume":"29","author":"A Vincze","year":"2011","unstructured":"Vincze A, Reglodi D, Zs H, Hashimoto H, Shintani H, Abraham H (2011) Role of pituitary adenylate cyclase activating polypeptide (PACAP) in myelination of the rodent brain: lessons from PACAP-deficient mice. Int J Dev Neurosci 29:923\u2013935","journal-title":"Int J Dev Neurosci"},{"key":"9762_CR82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.resp.2008.06.003","volume":"164","author":"RJ Wilson","year":"2008","unstructured":"Wilson RJ, Cummings KJ (2008) Pituitary adenylate cyclase-activating polypeptide is vital foe neonatal survival and the neuronal control of breathing. Respir Physiol Neurobiol 164:168\u2013178","journal-title":"Respir Physiol Neurobiol"},{"key":"9762_CR83","doi-asserted-by":"crossref","first-page":"e8596","DOI":"10.1371\/journal.pone.0008596","volume":"5","author":"K Yamada","year":"2010","unstructured":"Yamada K, Matsuzaki S, Hattori T et al (2010) Increased stathmin1 expression in the dentate gyrus of mice causes abnormal axonal arborizations. PLoS One 5:e8596","journal-title":"PLoS One"},{"key":"9762_CR84","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0306-4522(96)00168-6","volume":"74","author":"YZ Zhang","year":"1996","unstructured":"Zhang YZ, Hannibal J, Zhao Q et al (1996) Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience 74:1099\u20131110","journal-title":"Neuroscience"},{"key":"9762_CR85","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/00001756-199808240-00027","volume":"9","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, Danielsen N, Sundler F, Mulder H (1998) Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation. Neuroreport 9:2833\u20132836","journal-title":"Neuroreport"},{"key":"9762_CR86","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<953::AID-JNR21>3.0.CO;2-R","volume":"57","author":"X Zhou","year":"1999","unstructured":"Zhou X, Rodriguez WI, Casillas RA et al (1999) Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus. J Neurosci Res 57:953\u2013961","journal-title":"J Neurosci Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-012-9762-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9762-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:24:48Z","timestamp":1559427888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-012-9762-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,14]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9762"],"URL":"https:\/\/doi.org\/10.1007\/s12031-012-9762-0","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,14]]}}}